Publication | Closed Access

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

Pediatric Heart DiseaseRespiratory DiseasesPediatricsPediatric Lung DiseaseVirologyInfectious Respiratory DiseaseCongenital Heart DefectPulmonary MedicineYoung ChildrenMedicineCongenital Cardiac RepairSyncytial Virus